No it isn't, but it's the firm's who push the price low prior to dividend to buy up, and are using trumps tweets as momentum to get the ball rolling, essentially helping the SP decline
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
